Dr. Benjamin Sherman, D.O. Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 2265 Exchange St, Astoria, OR 97103 Phone: 503-338-4075 |
Dr. Douglas D Abbott, M.D. Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 2265 Exchange St, Astoria, OR 97103 Phone: 503-338-4075 Fax: 503-338-4076 |
News Archive
Young children with attention-deficit/hyperactivity disorder (ADHD) appear to be at greater risk for adolescent depression and/or suicide attempts five to 13 years after diagnosis, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with type 2 diabetes that were treated with a weekly injection of the breakthrough drug Semaglutide were able to achieve an average weight loss of nearly 10kg, according to a new study published in The Lancet today.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has submitted a Pediatric Investigation Plan (PIP) to the European Medicines Agency (EMEA) as part of the required filing process for approval of pixantrone for treating relapsed or refractory, aggressive non-Hodgkin's Lymphoma (NHL) in Europe. The PIP outlines how the company proposes to study the drug in children in order to benefit child health.
A recent analysis of national survey data reveals that over 1.6 million American adults use some form of complementary and alternative medicine (CAM) to treat insomnia or trouble sleeping according to scientists at the National Center for Complementary and Alternative Medicine (NCCAM), part of the National Institutes of Health.
› Verified 6 days ago